Cambridge medical devices pioneer CMR Surgical is commercialising a new robotics arm to revolutionise keyhole surgery.
The company secured $100 million (£74m) Series B funding in June 2018 – the largest ever private financing of a medical devices company in Europe. The $100m came from new investor the Zhejiang Silk Road Fund and existing investors Escala Capital Investments, LGT, Cambridge Innovation Capital and Watrium.
The company, incorporated fin 2014, now employs over 200 people and this year moved to a new 42,000 sq ft global headquarters on the outskirts of Cambridge.
In May 2019 CMR’s next-generation surgical robotic system Versius® successfully completed its first series of surgical procedures in humans. 30 laparoscopic procedures were completed as part of a clinical trial at Deenanath Mangeshkar Hospital & Research Center in Pune, India, by Consultant Oncologist and General Surgeon Dr. Dhananjay Kelkar and his team. The surgeries consisted of minor, intermediate and major gynaecological and upper gastrointestinal (GI) procedures.
The robot-assisted minimal access surgery market globally is estimated to reach $20 billion by 2025.